Physician profile
April Bussoletti
NPI 1134195092
$1,487.25
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $392 · 2022: $530 · 2023: $377 · 2024: $188.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $565.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $565.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $355.11 | 2021-2023 | Relistor |
| Boston Scientific Corporation | $219.73 | 2022-2023 | |
| Abbvie INC. | $197.45 | 2023-2024 | |
| Grt US Holding, INC. | $176.42 | 2022 | |
| Revance Therapeutics, INC. | $128.92 | 2024 | Daxxify |
| Medtronic, INC. | $125.96 | 2021 | |
| Protega Pharmaceutials INC | $75.00 | 2023 | Roxybond |
| Merz North America, INC. | $38.46 | 2024 | |
| Collegium Pharmaceutical, INC. | $33.94 | 2022 | |
| Idorsia Pharmaceuticals US INC | $31.04 | 2022-2023 | Quviviq |
| Forte Bio-Pharma LLC | $25.77 | 2021 | |
| Bioventus LLC | $23.48 | 2022 | |
| Redhill Biopharma INC. | $20.55 | 2021 | |
| Arbor Pharmaceuticals, INC. | $13.44 | 2021 | |
| Radius Health, INC. | $11.41 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spr Therapeutics, INC | $10.57 | 2023 | Sprint Pns System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw April Bussoletti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.